vs

Side-by-side financial comparison of Addus HomeCare Corp (ADUS) and Verisign (VRSN). Click either name above to swap in a different company.

Verisign is the larger business by last-quarter revenue ($425.3M vs $373.1M, roughly 1.1× Addus HomeCare Corp). Verisign runs the higher net margin — 48.5% vs 8.0%, a 40.5% gap on every dollar of revenue. On growth, Addus HomeCare Corp posted the faster year-over-year revenue change (25.6% vs 7.6%). Verisign produced more free cash flow last quarter ($285.1M vs $16.1M). Over the past eight quarters, Addus HomeCare Corp's revenue compounded faster (15.3% CAGR vs 5.2%).

Addus HomeCare Corp is a U.S.-based provider of comprehensive in-home care services, including personal care assistance, home health support, and hospice care. It primarily serves elderly, disabled, and chronically ill clients across multiple U.S. states, partnering with government payers, private insurers, and individual clients to deliver tailored care solutions.

Verisign, Inc. is an American company based in Reston, Virginia, that operates a diverse array of network infrastructure, including two of the Internet's thirteen root nameservers, the authoritative registry for the .com, .net, and .name generic top-level domains and the .cc country-code top-level domains, and the back-end systems for the .jobs and .edu sponsored top-level domains.

ADUS vs VRSN — Head-to-Head

Bigger by revenue
VRSN
VRSN
1.1× larger
VRSN
$425.3M
$373.1M
ADUS
Growing faster (revenue YoY)
ADUS
ADUS
+18.0% gap
ADUS
25.6%
7.6%
VRSN
Higher net margin
VRSN
VRSN
40.5% more per $
VRSN
48.5%
8.0%
ADUS
More free cash flow
VRSN
VRSN
$269.0M more FCF
VRSN
$285.1M
$16.1M
ADUS
Faster 2-yr revenue CAGR
ADUS
ADUS
Annualised
ADUS
15.3%
5.2%
VRSN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ADUS
ADUS
VRSN
VRSN
Revenue
$373.1M
$425.3M
Net Profit
$29.8M
$206.2M
Gross Margin
33.1%
88.5%
Operating Margin
11.3%
67.0%
Net Margin
8.0%
48.5%
Revenue YoY
25.6%
7.6%
Net Profit YoY
52.5%
7.7%
EPS (diluted)
$1.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADUS
ADUS
VRSN
VRSN
Q4 25
$373.1M
$425.3M
Q3 25
$362.3M
$419.1M
Q2 25
$349.4M
$409.9M
Q1 25
$337.7M
$402.3M
Q4 24
$297.1M
$395.4M
Q3 24
$289.8M
$390.6M
Q2 24
$286.9M
$387.1M
Q1 24
$280.7M
$384.3M
Net Profit
ADUS
ADUS
VRSN
VRSN
Q4 25
$29.8M
$206.2M
Q3 25
$22.8M
$212.8M
Q2 25
$22.1M
$207.4M
Q1 25
$21.2M
$199.3M
Q4 24
$19.5M
$191.5M
Q3 24
$20.2M
$201.3M
Q2 24
$18.1M
$198.8M
Q1 24
$15.8M
$194.1M
Gross Margin
ADUS
ADUS
VRSN
VRSN
Q4 25
33.1%
88.5%
Q3 25
32.2%
88.4%
Q2 25
32.6%
88.0%
Q1 25
31.9%
87.7%
Q4 24
34.2%
87.8%
Q3 24
31.8%
88.0%
Q2 24
32.5%
87.8%
Q1 24
31.4%
87.2%
Operating Margin
ADUS
ADUS
VRSN
VRSN
Q4 25
11.3%
67.0%
Q3 25
9.1%
67.8%
Q2 25
9.4%
68.5%
Q1 25
9.0%
67.4%
Q4 24
9.1%
66.7%
Q3 24
9.0%
68.9%
Q2 24
9.1%
68.8%
Q1 24
8.4%
67.4%
Net Margin
ADUS
ADUS
VRSN
VRSN
Q4 25
8.0%
48.5%
Q3 25
6.3%
50.8%
Q2 25
6.3%
50.6%
Q1 25
6.3%
49.5%
Q4 24
6.6%
48.4%
Q3 24
7.0%
51.5%
Q2 24
6.3%
51.4%
Q1 24
5.6%
50.5%
EPS (diluted)
ADUS
ADUS
VRSN
VRSN
Q4 25
$1.62
Q3 25
$1.24
Q2 25
$1.20
Q1 25
$1.16
Q4 24
$1.06
Q3 24
$1.10
Q2 24
$1.10
Q1 24
$0.97

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADUS
ADUS
VRSN
VRSN
Cash + ST InvestmentsLiquidity on hand
$580.5M
Total DebtLower is stronger
$121.0M
Stockholders' EquityBook value
$1.1B
$-2.2B
Total Assets
$1.4B
$1.3B
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADUS
ADUS
VRSN
VRSN
Q4 25
$580.5M
Q3 25
$617.7M
Q2 25
$593.8M
Q1 25
$97.0M
$648.5M
Q4 24
$98.9M
$599.9M
Q3 24
$222.9M
$644.9M
Q2 24
$173.3M
$689.9M
Q1 24
$76.7M
$924.7M
Total Debt
ADUS
ADUS
VRSN
VRSN
Q4 25
$121.0M
Q3 25
$150.6M
Q2 25
$169.1M
Q1 25
Q4 24
$218.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ADUS
ADUS
VRSN
VRSN
Q4 25
$1.1B
$-2.2B
Q3 25
$1.0B
$-2.1B
Q2 25
$1.0B
$-2.0B
Q1 25
$995.4M
$-2.0B
Q4 24
$970.5M
$-2.0B
Q3 24
$947.6M
$-1.9B
Q2 24
$921.7M
$-1.8B
Q1 24
$725.1M
$-1.6B
Total Assets
ADUS
ADUS
VRSN
VRSN
Q4 25
$1.4B
$1.3B
Q3 25
$1.4B
$1.4B
Q2 25
$1.4B
$1.4B
Q1 25
$1.4B
$1.4B
Q4 24
$1.4B
$1.4B
Q3 24
$1.2B
$1.5B
Q2 24
$1.1B
$1.5B
Q1 24
$1.0B
$1.7B
Debt / Equity
ADUS
ADUS
VRSN
VRSN
Q4 25
0.11×
Q3 25
0.14×
Q2 25
0.17×
Q1 25
Q4 24
0.23×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADUS
ADUS
VRSN
VRSN
Operating Cash FlowLast quarter
$18.8M
$289.6M
Free Cash FlowOCF − Capex
$16.1M
$285.1M
FCF MarginFCF / Revenue
4.3%
67.0%
Capex IntensityCapex / Revenue
0.7%
1.1%
Cash ConversionOCF / Net Profit
0.63×
1.40×
TTM Free Cash FlowTrailing 4 quarters
$103.8M
$1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADUS
ADUS
VRSN
VRSN
Q4 25
$18.8M
$289.6M
Q3 25
$51.3M
$307.7M
Q2 25
$22.5M
$202.5M
Q1 25
$18.9M
$291.3M
Q4 24
$10.4M
$231.5M
Q3 24
$48.5M
$253.4M
Q2 24
$18.8M
$160.4M
Q1 24
$38.7M
$257.3M
Free Cash Flow
ADUS
ADUS
VRSN
VRSN
Q4 25
$16.1M
$285.1M
Q3 25
$49.3M
$303.0M
Q2 25
$21.3M
$194.7M
Q1 25
$17.1M
$285.5M
Q4 24
$8.7M
$222.0M
Q3 24
$46.6M
$247.8M
Q2 24
$17.7M
$151.2M
Q1 24
$37.3M
$253.5M
FCF Margin
ADUS
ADUS
VRSN
VRSN
Q4 25
4.3%
67.0%
Q3 25
13.6%
72.3%
Q2 25
6.1%
47.5%
Q1 25
5.1%
71.0%
Q4 24
2.9%
56.1%
Q3 24
16.1%
63.4%
Q2 24
6.2%
39.1%
Q1 24
13.3%
66.0%
Capex Intensity
ADUS
ADUS
VRSN
VRSN
Q4 25
0.7%
1.1%
Q3 25
0.5%
1.1%
Q2 25
0.4%
1.9%
Q1 25
0.6%
1.4%
Q4 24
0.6%
2.4%
Q3 24
0.7%
1.4%
Q2 24
0.4%
2.4%
Q1 24
0.5%
1.0%
Cash Conversion
ADUS
ADUS
VRSN
VRSN
Q4 25
0.63×
1.40×
Q3 25
2.24×
1.45×
Q2 25
1.02×
0.98×
Q1 25
0.89×
1.46×
Q4 24
0.53×
1.21×
Q3 24
2.41×
1.26×
Q2 24
1.04×
0.81×
Q1 24
2.44×
1.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADUS
ADUS

Personal Care$286.0M77%
Hospice$70.0M19%
Home Health$17.1M5%

VRSN
VRSN

Segment breakdown not available.

Related Comparisons